These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 32237072)
1. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Zhang W; Wang H; Sun M; Deng X; Wu X; Ma Y; Li M; Shuoa SM; You Q; Miao L Cancer Commun (Lond); 2020 Mar; 40(2-3):69-80. PubMed ID: 32237072 [TBL] [Abstract][Full Text] [Related]
2. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis. Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034 [TBL] [Abstract][Full Text] [Related]
3. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways. Cui D; Zhao Y; Xu J Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567 [TBL] [Abstract][Full Text] [Related]
4. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858 [TBL] [Abstract][Full Text] [Related]
5. Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma. Roy S; Kumaravel S; Banerjee P; White TK; O'Brien A; Seelig C; Chauhan R; Ekser B; Bayless KJ; Alpini G; Glaser SS; Chakraborty S Cells; 2021 Nov; 10(11):. PubMed ID: 34831316 [TBL] [Abstract][Full Text] [Related]
6. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway. Cui D; Zhao Y; Xu J Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001 [TBL] [Abstract][Full Text] [Related]
7. The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis. Romero-Moreno R; Curtis KJ; Coughlin TR; Miranda-Vergara MC; Dutta S; Natarajan A; Facchine BA; Jackson KM; Nystrom L; Li J; Kaliney W; Niebur GL; Littlepage LE Nat Commun; 2019 Sep; 10(1):4404. PubMed ID: 31562303 [TBL] [Abstract][Full Text] [Related]
8. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer. Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929 [TBL] [Abstract][Full Text] [Related]
9. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219 [TBL] [Abstract][Full Text] [Related]
10. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α. Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249 [No Abstract] [Full Text] [Related]
12. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown. Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100 [TBL] [Abstract][Full Text] [Related]
13. Serum CXCL5 level is associated with tumor progression in penile cancer. Mo M; Li Y; Hu X Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33458757 [TBL] [Abstract][Full Text] [Related]
14. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome. Wang CY; Shang M; Zhou CL; Feng LZ; Zhou QS; Hu K Med Sci Monit; 2019 Jul; 25():5299-5305. PubMed ID: 31311916 [TBL] [Abstract][Full Text] [Related]
16. Spinal CXCL5 contributes to nerve injury-induced neuropathic pain via modulating GSK-3β phosphorylation and activity in rats. Xu W; Zhu M; Yuan S; Yu W Neurosci Lett; 2016 Nov; 634():52-59. PubMed ID: 27717828 [TBL] [Abstract][Full Text] [Related]
17. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer. Zhao J; Ou B; Feng H; Wang P; Yin S; Zhu C; Wang S; Chen C; Zheng M; Zong Y; Sun J; Lu A Oncotarget; 2017 Apr; 8(17):28442-28454. PubMed ID: 28415702 [TBL] [Abstract][Full Text] [Related]
19. A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation. Sokulsky LA; Garcia-Netto K; Nguyen TH; Girkin JLN; Collison A; Mattes J; Kaiko G; Liu C; Bartlett NW; Yang M; Foster PS J Immunol; 2020 Nov; 205(9):2468-2478. PubMed ID: 32948685 [TBL] [Abstract][Full Text] [Related]
20. The potential of CXCL5 as a target for liver cancer - what do we know so far? Xia J; Xu X; Huang P; He M; Wang X Expert Opin Ther Targets; 2015 Feb; 19(2):141-6. PubMed ID: 25495348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]